Watch Ticker

Precision BioSciences, Inc. Common Stock

Go to Precision BioSciences, Inc. Common Stock Website

$4.85

0.01 (0.21%)

Live

Previous Close

$4.84

Day Range

$4.6546 - $4.9

Previous Day Range

$4.6172 - $4.855

Market Cap

$51.2 million USD

Day Vol.

10096

Previous Day Vol.

39128

Currency

USD

Primary Exchange

Nasdaq

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

The CAR T-cell therapy pipeline is experiencing significant momentum, with over 180 companies actively developing more than 200 pipeline therapies. The report highlights promising pipeline candidates and recent advancements in the field, indicating the growing potential of this revolutionary cancer treatment approach.

Related tickers: RNAC, ACLX, AUTL, SANA, ORGS, DTIL, NVS, KYTX, KRBP, IVBIY, TCBP, TCBPW, IPSC, ALLO.

Read Full Article

Spherical Insights & Consulting - Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%

The global genetic engineering market is expected to grow from USD 1.35 billion in 2023 to USD 8.95 billion by 2033, driven by the increasing demand for biopharmaceutical products made through genetically altered processes. However, the high cost of R&D is a restraint on market growth.

Related tickers: TMO, CBUS, CRSP, SGMO, MKKGY, DTIL, NTLA, CRBU, A.

Read Full Article

Trending Tickers

Please sign in to view